EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Electronic patient-reported outcome platforms used in hematological cancers: a systematic review

Jessica Nikolovski, Marika Franklin, Eliza A Hawkes, Louise Acret, Jodie Palmer, Ozgu Serce, Zoe K McQuilten, Erica M Wood, Claudia Rutherford

Supportive Care in Cancer · 2026

DOI: 10.1007/s00520-026-11264-y ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Supportive Care in Cancer, 2026. Verfasst von Jessica Nikolovski und 8 weiteren Autor:innen. Beteiligte Einrichtung: Sydney Clinical Trials Centre, University of Sydney, Sydney, Australia. jessica.nikolovski@sydney.edu.au. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures, Hematologic Neoplasms. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MRFF KickStarter Scheme- La Trobe University, The University of Sydney.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The use of electronic patient-reported outcome measures (ePROMs) has demonstrated benefits in oncology; however, their use in hematological malignancies remains limited. We aimed to identify bespoke ePROM platforms used in hematology settings and describe their features, acceptability, usability, feasibility, implementation and uptake rates, and outcome data.

Methods

A systematic review was conducted following PRISMA 2020 guidelines. Electronic databases (MEDLINE, EMBASE, CINAHL, PsycINFO, Cochrane) and Google Play were searched for studies and mobile applications (apps) reporting on ePROM platforms in hematological cancer populations. Data were extracted about the following: characteristics, features, uses, and patient or clinician-reported data on platform acceptability, usability, feasibility, implementation, and evaluation outcomes.

Results

Fourteen total platforms were identified from 18 studies (reporting 13 unique ePROM platforms) and one platform known to authors. No additional platforms were identified through Google Play search. The included platforms were used in hematological research, clinical care, and registry settings and captured symptoms and quality of life using validated and customized PROMs. Delivery modes included websites and apps that featured automated prompts, clinician alerts, graphical feedback, and electronic medical record integration. Overall, usability was reported to be high; most platforms were acceptable to patients and clinicians. Feasibility and uptake varied, but several studies reported high patient engagement (> 80% completion rates). Positive outcomes included reduced symptom burden, improved treatment adherence, and enhanced patient-clinician communication.

Conclusions

The diversity of identified platforms reflects the wide range of hematological diseases, treatments, and care settings in which ePROMs may be applied, highlighting their flexibility and adaptability. Existing ePROM platforms used in hematological cancers vary substantially in features, purposes, and settings. Future work should focus on tailoring content, supporting implementation, and evaluating the impact of ePROM platforms on patient, clinician, and service outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient Reported Outcome MeasuresHematologic NeoplasmsHumansQuality of LifeDigital HealthMobile ApplicationsElectronic Health Records

Stichwörter der Autor:innen

CancerDigital healthElectronic patient-reported outcomesHematologySymptom monitoring

Autor:innen und Institutionen

  • Sydney Clinical Trials Centre, University of Sydney, Sydney, Australia. jessica.nikolovski@sydney.edu.au.
  • Faculty of Medicine and Health, Susan Wakil School of Nursing and Midwifery, Sydney Quality of Life Office (SQOLO), University of Sydney, Sydney, Australia. jessica.nikolovski@sydney.edu.au.
  • Sydney Clinical Trials Centre, University of Sydney, Sydney, Australia.
  • Faculty of Medicine and Health, Susan Wakil School of Nursing and Midwifery, Sydney Quality of Life Office (SQOLO), University of Sydney, Sydney, Australia.
  • The Daffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, Australia.
  • School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

Förderung

  • MRFF KickStarter Scheme- La Trobe University
  • The University of Sydney

Zitieren

APA

Nikolovski, J., Franklin, M., Hawkes, E. A., Acret, L., Palmer, J., Serce, O., McQuilten, Z. K., Wood, E. M., & Rutherford, C. (2026). Electronic patient-reported outcome platforms used in hematological cancers: a systematic review. Supportive Care in Cancer. https://doi.org/10.1007/s00520-026-11264-y

Vancouver

Nikolovski J, Franklin M, Hawkes EA, Acret L, Palmer J, Serce O, et al. Electronic patient-reported outcome platforms used in hematological cancers: a systematic review. Supportive Care in Cancer. 2026. doi:10.1007/s00520-026-11264-y

BibTeX
@article{Nikolovski2026,
  author = {Nikolovski, Jessica and Franklin, Marika and Hawkes, Eliza A and Acret, Louise and Palmer, Jodie and Serce, Ozgu and McQuilten, Zoe K and Wood, Erica M and Rutherford, Claudia},
  title = {Electronic patient-reported outcome platforms used in hematological cancers: a systematic review},
  journal = {Supportive Care in Cancer},
  year = {2026},
  doi = {10.1007/s00520-026-11264-y}
}
Kostenlos starten →